K-FasTaq DNA Polymerase
K-FasTaq DNA Polymerase
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- L/C,T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- enzyme, pcr, taq dna polymerase
- Category
- Chemicals , Other Chemicals
Apply a video call to the Supplier
Rapigen Biologicals Inc
- Membership
- PRO
- Recent Visit
- Jun 26, 2024
- Country / Year Established
-
South Korea
/
2018
- Business type
- Manufacturer
- Verified Certificate
-
1
| Product name | K-FasTaq DNA Polymerase | Certification | - |
|---|---|---|---|
| Category |
Chemicals
Other Chemicals |
Material | - |
| Keyword | enzyme , pcr , taq dna polymerase | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | 100 |
| Supply type | Available | HS code | 382200 |
Product Information
Description
Zamper K-FasTaq DNA Polymerase is an enzyme modified to increase the productivity and rate of amplification products. Since Zamper K-FasTaq DNA Polymerase Premix is optimized for fast PCR reaction, the total reaction time is shorter than the conventional PCR assay using Taq DNA polymerase, which is generally used.
Feature
Processivity & Sensitivity High amplification efficiency and high sensitivity
Productivity & Specificity Minimization of non-specific product generation and increased PCR productivity
Reaction time Short extension time (Targets less than 1 kb : 1 sec/kb, 1-3 kb Targets : 15 sec/kb)
Application
Routine PCR, Multiplex PCR, Fast PCR, Gene Expression Analysis, Genotyping Study
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | L/C,T/T | Shipping time | Negotiable |
- President
- HYE KYEONG KIM
- Address
- N106, 11-3, Techno 1-ro, , Yuseong-gu, Daejeon, Korea
- Product Category
- Chemical Reagents & Products,Other Chemicals
- Year Established
- 2018
- No. of Total Employees
- 1-50
- Company introduction
-
founded in January 2018 as a venture company, has made several attempts to develop and produce enzymes and monoclonal antibodies for molecular diagnostic kits and to raise their activities. We are aiming at developing enzymes and supplying them to research institutes or for academic researches and furthermore, world-class molecular diagnostic kits with these enzymes for the benefit of the world.
- Main Markets
-
Australia
China
India
Japan
Thailand
- Main Product
